Home > Income Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Revenue

    Back to Income Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

SYNCOM FORMULATIONS (INDIA) Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Net Sales ₹263 Cr₹224 Cr₹220 Cr₹18,482,242 Cr₹184 Cr

What is the latest Revenue of SYNCOM FORMULATIONS (INDIA) ?

The latest Revenue ratio of SYNCOM FORMULATIONS (INDIA) is ₹263 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹263 Cr
Mar2024₹224 Cr
Mar2023₹220 Cr
Mar2022₹18,482,242 Cr
Mar2017₹184 Cr

How is Revenue of SYNCOM FORMULATIONS (INDIA) Trending?

Years Revenue % Change
Mar2025 ₹263 Cr
17.45
Mar2024 ₹224 Cr
2.09
Mar2023 ₹220 Cr
-100.00
Mar2022 ₹18,482,242 Cr
10,050,222.98
Mar2017 ₹184 Cr -

Compare Revenue of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,102.6 Cr -2.9% -14.4% -23.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,528.0 Cr -3.1% 1.6% 5.6% Stock Analytics
DIVIS LABORATORIES ₹158,686.0 Cr -1.5% -3.4% 9.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,457.0 Cr -4.1% -1.2% 40.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,339.0 Cr -1.5% -0.9% 16.8% Stock Analytics
CIPLA ₹100,056.0 Cr -5.7% -7.8% -13.2% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-2.9%

-14.4%

-23.5%

SENSEX

-2.4%

-10.9%

0.2%


You may also like the below Video Courses